Analyst Consensus ?
ConsensusBuy25 ratings
Bullish2184.0%
Neutral416.0%
Bearish00.0%
FN2 Earnings Intelligence
Bunge Global S.A. analyst ratings
Bunge Global S.A. (BG) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$105.07Current
$90Low
$121.55Average
$150High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Apr 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 24, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 11, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 11, 2026 |
| UBS | Buy | Buy | Maintain | Feb 5, 2026 |
| B of A Securities | Buy | Buy | Maintain | Dec 2, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Oct 17, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 13, 2024 |
| HSBC | Buy | Hold | Upgrade | Feb 9, 2024 |
| Roth MKM | Buy | Buy | Maintain | Feb 5, 2024 |
| Baird | Neutral | Neutral | Maintain | Jan 23, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jan 10, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jun 23, 2022 |
| Bank of America | Buy | Neutral | Upgrade | Aug 2, 2016 |
| BB&T Capital | Buy | Buy | Maintain | Jul 12, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Oct 29, 2015 |
| Vertical Research | Buy | Buy | Maintain | Jul 7, 2015 |
| Feltl & Co. | Buy | Hold | Upgrade | Oct 23, 2013 |
| Miller Tabak | Hold | Buy | Downgrade | Oct 21, 2013 |
| PiperJaffray | Overweight | Neutral | Upgrade | Jun 12, 2013 |
| Piper Sandler | Overweight | Neutral | Upgrade | Jun 11, 2013 |
| Topeka | Buy | Hold | Upgrade | Jul 30, 2012 |
| Topeka Capital | Buy | Hold | Upgrade | Jul 29, 2012 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 29, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $105.07. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $150 | $126.31 | +42.8% | Apr 30, 2026 |
| Morgan Stanley | Steven Haynes | $130 | $112.75 | +23.7% | Mar 5, 2026 |
| UBS | Analyst unavailable | $145 | $117.23 | +38.0% | Feb 5, 2026 |
| BMO Capital | Analyst unavailable | $130 | $117.23 | +23.7% | Feb 5, 2026 |
| Stephens | Analyst unavailable | $130 | $117.23 | +23.7% | Feb 5, 2026 |
| Coker Palmer | Thomas Palmer | $117 | $110.06 | +11.4% | Jan 21, 2026 |
| Morgan Stanley | Analyst unavailable | $95 | $97.6 | -9.6% | Oct 27, 2025 |
| Barclays | Benjamin Theurer | $105 | $97.25 | -0.1% | Oct 21, 2025 |
| Stephens | Analyst unavailable | $115 | $95.33 | +9.5% | Oct 17, 2025 |
| BMO Capital | Analyst unavailable | $110 | $93.09 | +4.7% | Oct 16, 2025 |
| Morgan Stanley | Steven Haynes | $83 | $83.14 | -21.0% | Aug 12, 2025 |
| CFRA | Arun Sundaram | $90 | $85.86 | -14.3% | Oct 30, 2024 |
| HSBC | Wesley Brooks | $105 | $104.06 | -0.1% | Apr 25, 2024 |
| Coker Palmer | Thomas Palmer | $122 | $105.79 | +16.1% | Apr 24, 2024 |
| UBS | Analyst unavailable | $133 | $94.47 | +26.6% | Dec 14, 2022 |
| Morgan Stanley | Analyst unavailable | $120 | $115.76 | +14.2% | May 2, 2022 |
| Credit Suisse | Analyst unavailable | $140 | $116.4 | +33.2% | Apr 28, 2022 |
| BMO Capital | Analyst unavailable | $144 | $118.96 | +37.1% | Apr 28, 2022 |
| Barclays | Analyst unavailable | $135 | $115.56 | +28.5% | Apr 25, 2022 |
Track every rating change on BG the moment it posts. Free to start.
Start free